ArticleFrontiers in medicine2026
The red cell distribution width to albumin ratio as a novel biomarker for predicting short-term mortality in severe pulmonary sepsis: a retrospective study with dual-cohort validation.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Red Cell Distribution Width to Albumin Ratio (RAR) is a biomarker that reflects a patient's nutritional status, inflammatory response, and oxidative stress, showing significant potential in critical care medicine. To investigate its prognostic value, we conducted a retrospective study using a dual-cohort design to assess the association between RAR and short-term (28-day) mortality in patients with pulmonary sepsis. Materials and methods: We retrospectively identified patients with sepsis secondary to pulmonary infections from the Binzhou Medical University Hospital medical records and the Medical Information Mart for Intensive Care (MIMIC-IV) database. To examine the association between RAR and short-term adverse outcomes in these patients, we employed several statistical methods, including Kaplan-Meier survival curves, multivariable Cox regression, and restricted cubic spline (RCS) analysis. Subsequently, we applied machine learning algorithms-namely the Boruta algorithm, LASSO-COX regression, and Random Forests-to identify the most predictive features. These features were then used to develop a final multivariable Cox regression model for risk prediction. The performance of this predictive model was evaluated using receiver operating characteristic (ROC) curve analysis. Result: The final analysis included 6,065 patients with pulmonary sepsis. The 28-day ICU and in-hospital mortality rates were 20.50 and 19.30%, respectively. In the fully adjusted multivariable model, a higher RAR was significantly associated with increased 28-day ICU and in-hospital mortality, whether treated as a continuous or categorical variable. For each unit increase in the continuous RAR score, the hazard ratios (HR) for 28-day ICU and in-hospital mortality were 1.52 (95% CI: 1.28-1.80) and 1.30 (95% CI: 1.09-1.55), respectively. Similarly, when compared to the low RAR group, the high RAR group had hazard ratios of 1.45 (95% CI: 1.23-1.70) and 1.29 (95% CI: 1.09-1.52) for the two outcomes. The restricted cubic spline (RCS) analysis revealed a positive dose-response relationship between RAR levels and short-term adverse outcomes. Furthermore, the risk prediction model incorporating RAR and eight other independent predictors demonstrated superior performance in identifying high-risk patients compared to traditional critical illness scoring systems, as shown by receiver operating characteristic (ROC) analysis. All findings were consistently validated in the external cohort. Conclusion: In conclusion, our study demonstrates a significant inverse association between the RAR and short-term survival in patients with severe pulmonary sepsis. The RAR-based scoring system we developed shows promise as a practical adjunct tool for clinical risk assessment. Prospective validation is warranted to confirm its utility in improving risk stratification for this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.